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Purpose: To use a graphic processing unit (GPU) calculation engine to implement a fast 3D pre-treatment dosimetric
verification procedure based on an electronic portal imaging device (EPID).
Methods: The GPU algorithm includes the deconvolution and convolution method for the fluence-map calculations,
the collapsed-cone convolution/superposition (CCCS) algorithm for the 3D dose calculations and the 3D gamma
evaluation calculations. The results of the GPU-based CCCS algorithm were compared to those of Monte Carlo
simulations. The planned and EPID-based reconstructed dose distributions in overridden-to-water phantoms and
the original patients were compared for 6 MV and 10 MV photon beams in intensity-modulated radiation therapy
(IMRT) treatment plans based on dose differences and gamma analysis.
Results: The total single-field dose computation time was less than 8 s, and the gamma evaluation for a 0.1-cm
grid resolution was completed in approximately 1 s. The results of the GPU-based CCCS algorithm exhibited good
agreement with those of the Monte Carlo simulations. The gamma analysis indicated good agreement between
the planned and reconstructed dose distributions for the treatment plans. For the target volume, the differences
in the mean dose were less than 1.8%, and the differences in the maximum dose were less than 2.5%. For the
critical organs, minor differences were observed between the reconstructed and planned doses.
Conclusions: The GPU calculation engine was used to boost the speed of 3D dose and gamma evaluation
calculations, thus offering the possibility of true real-time 3D dosimetric verification.
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As the frequency of dose prescriptions and the complex-
ity of radiotherapy techniques increase, so too do the de-
mands for accurate and efficient methods of verifying
the doses delivered to patients. Hence, dosimetric verifi-
cation is a prerequisite to ensure correct treatment plan-
ning and delivery. In recent years, an increasing number
of reports have begun to focus on the 3D dosimetric
verification of intensity-modulated radiation therapy
(IMRT) treatment plans [1-3]. Most planar dosimetric
verifications are based on uniform phantoms, but this
method cannot be used to determine the algorithm error* Correspondence: stslxw@mail.sysu.edu.cn
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unless otherwise stated.of a treatment planning system (TPS) with respect to in-
homogeneities. Nelms et al. have reported that there is a
lack of correlation between conventional IMRT quality
assurance (QA) performance metrics (gamma pass rate)
and dose errors in anatomical regions of interest. There
is no clear relation between the gamma pass rate and the
error in dose–volume histograms (DVHs) [4]. 3D dosi-
metric verifications can yield more intuitive anatomy-
based 3D dose differences for clinical verifications and
other detailed evaluation indices, such as the DVH.
Because of their sub-millimeter resolution, real-time
response and lower workload, electronic portal imaging
devices (EPIDs) are often utilized for pre-treatment and
in vivo measurements [1,2,5-7]. There are two ap-
proaches to using an EPID for 3D dosimetric verifica-
tions. One technique is to calculate the 3D doseis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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TPS. Steciw et al. have reported the use of a TPS to cal-
culate dose distributions based on the fluences of treat-
ment fields that were measured using an EPID [8]. This
method can be easily performed in clinical practice
because no effort is required for the independent dose-
calculation algorithm and model commissioning. How-
ever, the effect of the TPS calculation errors cannot be
estimated. Moreover, not all commercial TPSs have
functions to export fluence maps or to calculate doses
based on input fluence maps. The other technique is to
use an independent dose-calculation algorithm. Wendling
et al. have reported the use of the “back-projection” algo-
rithm for this purpose [9]. This method is simple and has
been used clinically in their institution [6]. The model is
“water-equivalent,” as the parameters are determined
under homogeneous conditions. For verifications of lung
treatments in which inhomogeneities are important, a cor-
rection method known as the “in aqua vivo” method is ap-
plied [10]. Elmpt et al. have implemented 3D dose
verifications based on Monte Carlo simulations. If imple-
mented correctly, such simulations can provide, in
principle, the highest accuracy that is currently available
[2]. Recent publications have reported the implementation
of a pencil-beam algorithm for fast 3D dosimetric veri-
fications [11-13]. Because of the simplicity of this
pencil-beam algorithm, its computation speed is very
fast. However, its limitations cause it to be unsuitable
for application to inhomogeneous tissues [14].
In clinical applications, whether for pre-treatment or
for in vivo dosimetric verifications, two aspects must be
considered: first, the computation time must be consid-
ered, with the potential goal of real-time verification,
and second, the accuracy in inhomogeneous tissues
must be examined. The collapsed-cone convolution/
superposition (CCCS) [15] algorithm is often used in
radiotherapy TPSs. The calculation accuracy of the
CCCS algorithm for inhomogeneous tissues is accept-
able. A recent report demonstrated that the results pro-
duced by the CCCS dose engine that is used in the
TomoTherapy® TPS are consistent with Monte Carlo
results within 1%/1 mm in water and 2%/2 mm in the
lung, except in cases involving a small field (1.25 cm ×
1.25 cm) and a tissue–air interface [16]. Thus, the use of
the CCCS algorithm is a compromise between the compu-
tation time and the accuracy in inhomogeneous tissues.
Although the CCCS algorithm incorporates the collapsed-
cone approximation, which allows the calculation com-
plexity to be reduced in comparison with full-volume
point-to-point convolution, it is still computationally
demanding, especially for IMRT, which involves many
fields or segments. Graphic processing units (GPUs) are
increasingly being used for scientific applications, in-
cluding 3D dosimetric calculations, that can beaccelerated by exploiting the parallel architecture and
unprecedented computing power density of GPUs
[17-20]. Quan et al. have reported that a GPU algo-
rithm using exponential cumulative–cumulative kernels
(CCKs) is 1000–3000 times faster than a highly opti-
mized single-threaded CPU implementation using a
tabulated CCK [19]. Computation times on the order of
seconds can be achieved. Thus, a GPU-based CCCS al-
gorithm demonstrates good prospects for achieving
true real-time 3D dosimetric verifications.
An EPID can be used to determine the delivery errors
of treatment plans, and an accurate independent dose-
calculation algorithm can be used to estimate the errors
of TPS dose calculations, including scenarios involving
the treatment of inhomogeneous sites such as lung tis-
sues and oral-nasal cavities, and to cross-check the TPS
modeling, which is strongly dependent on the input
measurement data. The computation speed can be
boosted via GPU implementation. The GPU implemen-
tation of fast EPID-based 3D pre-treatment dosimetric
verifications is presented in this paper. The GPU algo-
rithm includes the deconvolution and convolution
method for the fluence-map calculations, the CCCS al-
gorithm for the 3D dose calculations and the 3D gamma
evaluations. The combination of an EPID-based ap-
proach and a GPU-based approach can effectively re-
duce the measurement workload and calculation time
that are required for pre-treatment verifications. Fur-
thermore, real-time IMRT dosimetric verifications and
dose-guided radiation therapy pose stringent require-
ments in terms of measurement and calculation-time
capabilities. The combination of features provided by
EPIDs and GPUs can satisfy these requirements.
Methods
EPID image acquisition
A Trilogy linear accelerator system (Varian Medical
Systems, Palo Alto, CA, USA) with an aS1000 EPID
(Varian Medical Systems, Palo Alto, CA, USA) was
employed in this study. Both 6 MV and 10 MV photon
beams were used for all measurements. The physical
size of the EPID was as follows: the EPID had a sensi-
tive area of 40 cm × 30 cm in size, and the effective
pixel size was 0.04 cm × 0.04 cm. The pre-treatment
EPID measurement was performed in air without a
phantom/patient. Because the EPID images were used
as the input for subsequent dose calculations, it was ne-
cessary to completely capture the treatment fields in
the cross-plane direction. The effective source-to-
detector distance was set to 140 cm. Image acquisition
was performed in integrated mode, and offset correc-
tion, gain correction and pixel correction were per-
formed for each image. Because of the robotic arm that
is located directly beneath the sensitive area of the
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deleterious effect when the EPID is used for dosimetric
purposes [21-23]. The backscatter correction kernel
was modeled as a radially symmetric Gaussian and ap-
plied to the raw EPID data [24]. To ensure positioning
accuracy during image acquisition, a gantry-angle-
dependent correction associated with the panel position
displacement was applied [25]. The EPID displacement
was measured by comparing the image acquired at each
gantry angle to the 0° image in the 10 cm × 10 cm field.
Fluence-map calculation
The pixel values of the EPID images, which captured the
treatment fields during air delivery, were reconstructed
into fluence maps at a source–axis distance (SAD) of
100 cm using the deconvolution and convolution
method.
In our previous studies [26], the EPID, which consists
of several layers, was treated as a uniform water-
equivalent phantom. The relationship between the pixel
values of the EPID images and the dose values on the
central plane of the 20-cm-thick virtual water phantom,
which was placed at a source-to-surface distance (SSD)
of 90 cm, can be represented as follows:
Dij ¼ cad⋅Pij ⊗−1 KEPIDij ⊗ KWaterij ð1Þ
where ⊗ and ⊗ − 1 denote the convolution and deconvo-
lution operators, respectively. Every pixel in the EPID
image is referred to by its indices i and j; Pij is the pixel
value of the EPID image that is projected to the phan-
tom level, Dij is the dose at the phantom level, cad is the
absolute dose calibration factor, KEPIDij is the EPID scat-
ter kernel that is used to obtain the incident fluence
map, and KWaterij is the convolution kernel that is used to
calculate the dose distribution in the water phantom.
In this study, this model was used to reconstruct the
EPID image into a fluence map; thus, equation (1) was
simplified as follows:
Dij ¼ cad⋅Pij ⊗−1 KEPIDij ð2Þ
with
KEPIDij ¼ 1−cð Þ exp ‐μSdij
 þ c⋅ exp ‐μLdij
  ð3Þ
Here, dij is the distance from the center of the kernel
to a pixel ij. μS and μL are the attenuation coefficients,
which depend on the energy and the material. There are
two terms in this equation. The first term, which con-
tains μS, is the short-range primary dose component. It
describes the energy per unit mass imparted by the
charged particles released as a result of the first inter-
action of a primary photon. The second term, which
contains μL, is the long-range scatter dose component. Itdescribes the energy imparted by charged particles set in
motion by secondary photons, i.e., by scattered, brems-
strahlung and annihilation photons.
Because of the broad distribution of photon energies
within the phantom and the EPID, there will be an ef-
fective attenuation coefficient for the energy spectrum.
Instead of the use of multiple monoenergetic kernels
based on the beam’s energy spectrum, μS and μL were
treated as free parameters in the fit procedure. For each
nominal energy of the linear accelerator, the parameters
of KEPIDij are different. These parameters were deter-
mined using the central point dos × es, which were mea-
sured using an ion chamber in air for fields of 3 cm ×
3 cm to 20 cm × 20 cm. The parameters of the KEPIDij
kernel that yielded the minimum variance could thus be
determined via the golden-section search algorithm [27].
Because the structure of an EPID is invariant, these pa-
rameters were constants once the fit procedure had been
completed.
A simple exponential kernel was introduced to reduce
the noise arising from the application of the deconvolu-
tion operator, and a Gaussian function was used to cor-
rect the “horns” from the beam profile.
To improve the calculation speed, a fast Fourier trans-
form (FFT) was used. The FFT was applied using the
CUFFT library from the NVIDIA® CUDA™ library, which
is highly optimized for computing parallel FFTs using an
NVIDIA GPU.
The EPID-based fluence maps for fields of 3 cm ×
3 cm to 20 cm × 20 cm were compared to the ion-
chamber results. The Sc factor and the dose profiles in
air were obtained using a 0.13-cc ion chamber (IBA
Dosimetry GmbH, Schwarzenbruck, Germany) with a
buildup cap by scanning an empty 3D water tank (Blue
Phantom, IBA Dosimetry GmbH, Schwarzenbruck,
Germany) at an SAD of 100 cm.3D dose reconstruction using a GPU
3D dose-calculation algorithm
The fluence-map-based CCCS algorithm includes two
independent components: the calculation of the total en-
ergy released per mass (TERMA) and the convolution/
superposition (CS) calculation of the energy deposition [15].
The TERMA calculation models the primary photons
that interact with the material. Because the CCCS algo-
rithm was used for EPID-based 3D dosimetric verifica-
tions in this study, a measured source model was used
for the TERMA calculation instead of a theoretically cal-
culated source model, which must account for all ele-
ments of the system, including the flattening filter, the
collimator system, the multi-leaf system, etc.[12]. The
EPID-based fluence maps, which included the intensity
of the beam emitted from the head of the linear
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the beam was obtained from the phase-space files that
were simulated for the Varian Trilogy 6-MV and 10-MV
photon beams using BEAMnrc [28], and the geometry
and material parameters of the linear accelerator were
obtained from the manufacturer. The TERMA calcula-
tion was performed based on the electron density and
the linear attenuation coefficient of water during the ray
tracing, the latter of which was obtained from the
National Institute of Standards and Technology (NIST).
The calculation had a complexity of O (N3) for N3 vox-
els. Each voxel was calculated by one GPU thread.
Three types of kernel expressions can be used in the
discretization of the CCCS algorithm: the differential
kernel (DK), the cumulative kernel (CK) and the cumu-
lative–cumulative kernel (CCK) [29]. Lu et al. reported
that the CCK is the most accurate because of its inher-
ent voxel integration; therefore, the CCK was used in
this study. The CCK was pre-calculated from discrete
Monte Carlo kernels, which were simulated using the
edknrc program [30] for uniform water. The lookup
method based on tabulated kernels was used in the cal-
culation. The kernels were scaled in accordance with the
electron densities between the interaction point and the
receiving points to allow the water kernels to be applied
to arbitrary inhomogeneous media [15,29]. Considering
that the kernel intensity had an angular distribution, the
collapsed-cone directions were divided into non-
uniformly sampled zenith angles to improve the calcula-
tion speed. The collapsed-cone directions were divided
as follows: 22 uniformly sampled angles from 0° to 44°, 1
angle from 44° to 50°, 9 uniformly sampled angles fromFigure 1 A schematic diagram of the heterogeneous slab phantom and se50° to 95°, 1 angle from 95° to 120° and 3 uniformly
sampled angles from 120° to 180°. The calculation also
included 8 uniformly sampled azimuthal angles. In total,
280 collapsed-cone directions were used. Each voxel was
calculated in one kernel direction by one GPU thread and
then looped through all directions. This method is well
suited to GPU implementation because adjacent threads
can be used to access adjacent memory locations [19].Algorithm heterogeneity evaluation
A slab phantom similar to that used by Ahnesjo [15]
was employed in this study. This phantom consisted of
slabs of simulated tissues (adipose (A, density =
0.920 g cm−3), muscle (M, density = 1.040 g cm−3), bone
(B, density = 1.850 g cm−3) and lung (L, density =
0.250 g cm−3)). The thickness of the phantom was
30 cm, and its structure is illustrated in Figure 1. The
source-to-surface distance (SSD) was 85 cm. The sizes
of the evaluation fields were 3 cm × 3 cm, 10 cm ×
10 cm and 20 cm × 20 cm. The calculation methods in-
cluded (1) the GPU-based CCCS algorithm, (2) a full
Monte Carlo simulation and (3) the analytical anisotropic
algorithm (AAA). The size of the calculation grid for all
methods was 3 mm× 3 mm× 3 mm. The EGSnrc user
code DOSRZnrc [31], with the phase-space files men-
tioned in the previous section, was used to simulate the
dose delivered to the material. Because the treatment
plans were created and optimized using Eclipse v10.0.28
(Varian Medical Systems, Palo Alto, CA, USA), which uses
the AAA for dose calculations, the AAA was also consid-
ered in the evaluation.tup.
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Treatment planning
One head-and-neck IMRT treatment plan and one lung
IMRT treatment plan were chosen for 6 MV dosimetric
verification. One lung IMRT treatment plan and one
prostate IMRT treatment plan were chosen for 10 MV
dosimetric verification. The treatment plans were cre-
ated and optimized using Eclipse v10.0.28, and the AAA
was used as the dose-calculation algorithm. The size of
the calculation grid was 3 mm × 3 mm× 3 mm. Nine ra-
diation fields were used for the head-and-neck and pros-
tate treatment plans, and five radiation fields were used
for the lung treatment plan. The optimization objective
functions of the targets were generally set such that the
planning target volume (PTV) received at least 95% of
the prescribed dose. The optimization objective func-
tions of the other normal tissues were set following clin-
ical requirements. The prescribed doses for the 6 MV
head-and-neck, 6 MV lung, 10 MV lung and 10 MV
prostate plans were 68.2 Gy, 66.0 Gy, 66.0 Gy and
67.5 Gy, respectively.
Dosimetric verifications
The 3D dose-reconstruction results that were obtained
based on the EPID were compared to the TPS results.
Because a measured source model was used in our dose
calculation, it was difficult to directly quantify the differ-
ences in the dose-calculation algorithms and the sources
of delivery error for these two different methods. It is
well known that dose-calculation algorithms, including
the CCCS algorithm and the AAA, are accurate in a uni-
form water phantom [15,29,32]. Therefore, the material
within the patient’s body structure was first overridden
to water (mass density 1.0 g cm-3). This aided in exclud-
ing any inherent difference between the dose-calculation
algorithms when quantifying the effect of the delivery
error. The TPS was used to recalculate the dose distribu-
tions in the overridden water phantom for the verifica-
tion plans, and the EPID-based fluence maps were used
to reconstruct the dose distributions in the same phan-
tom. The comparisons were performed with respect to
the following: 1) Dose differences, including the differ-
ences in the mean doses (Dmean) and the maximum
doses (Dmax) to the targets and the organs at risk
(OARs). The percent dose differences were calculated
using the following equations:
Dif f mean ¼ DEPIDmean−DTPSmean
 
=Dprescribed  100% ð4Þ
Dif f max ¼ DEPIDmax −DTPSmax
 
=Dprescribed  100% ð5Þ
2) 3D gamma evaluations. The same areas that were
used for the dose comparisons were treated as theregions of interest (ROIs). The dose grid size was
resampled to 1 mm × 1 mm× 1 mm before the gamma
evaluation was performed. We set 3% of the maximum
dose as the dose criterion and 3 mm as the distance cri-
terion (henceforth referred to as the 3%/3 mm criterion),
and a tighter 2%/2 mm criterion was also evaluated. A
statistical evaluation was performed to determine the
point at which the dose was greater than 10% of the
maximum dose.
The 3D dose-reconstruction results and the TPS re-
sults from the original patient CTs were also considered
for comparison. These comparisons were performed
with respect to the following: 1) Dose differences, in-
cluding those in the Dmean and Dmax values of the targets
and OARs, and 2) 3D gamma evaluations. The evalu-
ation criteria were the same as those listed above.
One disadvantage of the 3D gamma evaluation is its
long computation time [33,34]. With the dose grid size
resampled to 1 mm × 1 mm× 1 mm, the computation
time using a fast algorithm for the body gamma evalu-
ation would be approximately 1 minute [34]. However,
applying a GPU implementation of the gamma evalu-
ation can reduce the computation time [35]. Because
GPU texture memory provides high-efficiency trilinear
interpolation for 3D data, the dose data were bound to
the GPU texture memory for the resampling process.
The gamma index of each voxel was calculated by a sep-
arate GPU thread. Voxels with dose values lower than
the threshold were excluded from the calculation
process.
All calculation algorithms discussed above were imple-
mented in Visual C++. All computations were per-
formed on a notebook with an Intel Core i7-4700MQ
2.40 GHz CPU and an NVIDIA GTX-765 M video card.
Results
Evaluations of EPID-based fluence maps
Figure 2 shows the central-point relative dose values in
air that were measured using the ion chamber and the
EPID for square fields of various sizes. When our decon-
volution model correction was applied to the raw EPID
data, the maximum difference between the EPID results
and the ion-chamber measurements was less than 0.5%
for both the 6 MV and 10-MV photon beams. Figure 3
shows the fluence profiles on the central axis that were
measured using the ion chamber and the EPID after cor-
rection. The agreement was good for both the cross-
plane direction and the in-plane direction.
Evaluations of dose algorithm heterogeneity
Figure 4 presents the axial-depth–dose curves in the
heterogeneous slab phantom that were obtained using
the various algorithms for the 6 MV photon beam. The
percent dose differences presented in this section were
Figure 2 The central point dose values of the square-field results for the ion chamber (black points), the EPID before correction (dashed lines)
and the EPID after correction (solid lines) for a) the 6 MV photon beam and b) the 10 MV photon beam. The relative doses were normalized to
the central dose of the 10 cm × 10 cm field.
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2 cm depth in the case of the 6 MV beam and for a
5 cm depth in the case of the 10 MV beam; these depths
correspond to positions in the muscle slab near the
depth at which the maximum dose occurred. The CCCS
results agreed well with the results of the Monte Carlo
simulation. The dose difference was less than 1.5%, ex-
cept at the interfaces of different materials. For the
AAA, the dose results for the low-density lung region
were lower than the Monte Carlo results. The largest
dose difference was 7.5%. The dose results for the high-
density bone region were higher than the Monte Carlo
results, and the largest dose difference was 15%. Figure 5Figure 3 The fluence profiles on the central axis determined using the EPI
the cross-plane central axis for the 6 MV beam; b) the in-plane central axis
and d) the in-plane central axis for the 10 MV beam. The relative doses wepresents the axial-depth–dose curves in the heteroge-
neous slab phantom that were obtained using the vari-
ous algorithms for the 10 MV photon beam. In this case,
the CCCS results again agreed well with the results of
the Monte Carlo simulation except at the interfaces of
different materials. For the AAA, the results were super-
ior to those obtained in the 6-MV case. The largest dose
difference in the low-density lung region was 6.4%, and
that in the high-density bone region was 9.0%.
3D dosimetric verifications
Table 1 presents the gamma pass rates of the gross tar-
get volume (GTV), the clinical target volume (CTV), theD (black solid lines) and using the ion chamber (red dashed lines): a)
for the 6 MV beam; c) the cross-plane central axis for the 10-MV beam;
re normalized to the central dose of the 10 cm × 10 cm field.
Figure 4 The axial-depth–dose curves in the heterogeneous slab phantom that were obtained using the various algorithms for the 6 MV photon
beam and the different field sizes: a) field size of 3 cm × 3 cm, b) field size of 10 cm × 10 cm and c) field size of 20 cm × 20 cm.
Figure 5 The axial-depth–dose curves in the heterogeneous slab phantom that were obtained using the various algorithms for the 10 MV
photon beam and the different field sizes: a) field size of 3 cm × 3 cm, b) field size of 10 cm × 10 cm and c) field size of 20 cm × 20 cm.
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Table 1 The percentage of voxels with a gamma index smaller than 1 for the comparison between the EPID-based
results and the TPS results
Plan structure Head & neck (6 MV) Lung (6 MV) Lung (10 MV) Prostate (10 MV)
Pw(%) Pm(%) Pw(%) Pm(%) Pw(%) Pm(%) Pw(%) Pm(%)
Body 2%/2 mm 74.7 73.2 90.4 83.5 88.9 90.3 94.8 94.1
3%/3 mm 93.7 93.1 99.8 99.4 99.0 99.1 99.4 99.6
GTV 2%/2 mm 97.5 82.2 94.9 77.4 98.7 76.8 87.8 80.1
3%/3 mm 100.0 97.5 100.0 96.1 100.0 96.2 97.6 93.0
CTV 2%/2 mm 79.0 71.4 97.3 80.8 99.2 84.8 87.8 83.0
3%/3 mm 97.8 93.4 100.0 97.2 100.0 97.6 97.6 95.6
PTV 2%/2 mm 73.6 70.1 92.8 79.9 95.5 87.0 92.3 83.9
3%/3 mm 96.6 92.9 99.7 97.3 99.9 98.5 99.6 98.6
Pw represents the pass rate of the patient body overridden to water, and Pm represents the pass rate of the original material.
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the treatment plans. The results for the patient body
overridden to water and for the original material are
shown. The gamma statistics are within the 10% isodose
contours. Good results were obtained using the 3%/
3 mm criterion for the planned and EPID-based recon-
structed dose distributions in both cases. However, for
the tight criterion (2%/2 mm), the pass rates of the ori-
ginal material were decreased compared with the
overridden-to-water results; the maximum difference
was 22%.
The detailed statistics of the dose differences for the
targets and the OARs of the patient body overridden to
water are summarized in Table 2, and the results for the
original material are summarized in Table 3. Acceptable
agreement was observed between the EPID-based results
and the planned results for both the target regions and
the OARs. However, the dose differences in the case of
the original material were slightly larger than those inTable 2 Comparison between the planned doses and the EPID
patient body overridden to water









GTV 0.03 1.97 1.16 0.56
CTV -0.28 1.98 0.34 -1.49
PTV -0.52 0.82 -0.27 -1.49
Brain stem -0.61 -2.30
Parotid 2.08 3.09
Spinal cord -0.67 -0.72 -1.13 -1.68




Colonthe overridden-to-water case. In the case of the patient
body overridden to water, the average differences in the
mean doses and the maximum doses to the target re-
gions were 0.11 ± 0.52% and 0.32 ± 1.17%, respectively,
and the corresponding average values for the OARs were
-0.34 ± 1.35% and 0.12 ± 1.74%, respectively. In the case
of the original material, the average differences in the
mean doses and the maximum point doses to the target
regions were 0.57 ± 0.71% and 1.34 ± 0.66%, respectively,
and the corresponding average values for the OARs were
-0.80 ± 2.05% and 0.41 ± 2.32%, respectively.
Computation times for dosimetric verifications
Table 4 lists the computation times associated with the
various components of the calculation for the GPU im-
plementation, including the initialization of the CUDA
subsystem, the fluence-map calculation, the CCCS calcu-
lation of one field and the gamma evaluation of the
body. According to these results, the total dose-based doses for the treatment plans in the case of the
Lung (10 MV) Prostate (10 MV)








0.53 0.56 0.64 0.56
-0.2 -0.82 0.65 0.66







Table 3 Comparison between the planned doses and the EPID-based doses for the treatment plans in the case of the
original material

















GTV 0.55 0.64 1.13 1.56 1.15 1.53 1.75 2.48
CTV 0.01 1.08 0.62 0.95 0.65 1.29 1.52 2.20
PTV -0.38 1.08 -0.50 0.24 -0.24 0.78 0.62 2.20
Brain stem -4.54 -3.95
Parotid 1.74 2.95
Spinal cord -1.50 -3.15 -2.51 -0.27 -3.07 -0.83
Both lungs -0.93 2.03 -1.27 2.18
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and the gamma evaluation was completed in approxi-
mately 1 s.
Discussion
Treatment verification using a 3D dose reconstruction
based on information acquired in the treatment room is
feasible. EPID-based reconstruction can be used to de-
termine the delivery errors of a treatment plan and to
estimate the errors of a TPS dose-calculation algorithm.
During treatment, the output of the linear accelerator
may differ from the planned delivery determined using
the TPS. For example, the positioning accuracy of the
multi-leaf collimator may lead to differences in the deliv-
ered and planned dose distributions. Because of its high
resolution and linear dose response, an EPID can effect-
ively detect the delivery errors of a linear accelerator
[36,37]. Accurate and reliable dose-calculation algo-
rithms that consider density inhomogeneities are neces-
sary, especially for the head, neck and thorax [38,39].
For this purpose, the calculation accuracy of the CCCS
algorithm for inhomogeneous tissues is acceptable
[16,29]. An independent dose-calculation algorithm
based on the CCCS algorithm was implemented to suc-
cessfully estimate the errors of a TPS dose-calculation al-
gorithm. In this study, fluence maps were obtained
based on EPID measurements. These fluence maps wereTable 4 GPU computation times for dose calculations and gam
Volume (cm3) Initialization (s) Fluence map
Head & Neck 48 × 30 × 21.6 0.225 0.264
Lung 54 × 15 × 22.8 0.236 0.263
Prostate 40.8 × 36 × 31.8 0.231 0.266used to reconstruct the doses delivered to overridden-
to-water phantoms and the original patients. According
to the gamma analysis results, good results were ob-
tained for both cases using the 3%/3 mm criterion. The
average gamma pass rates were greater than 94%. How-
ever, when a tighter criterion (2%/2 mm) was used, the
pass rates of the original patients were decreased com-
pared with the pass rates of the overridden-to-water
phantoms. The maximum decreases for the head-and-
neck, lung and prostate treatment plans were approxi-
mately 15%, 20% and 8%, respectively. For both 6 MV
treatment plans (head-and-neck and lung), the EPID-
based doses to the spinal cord were found to be lower
than the planned doses; based on the heterogeneity
evaluation, this result can be attributed to the presence
of high-density bone material around the spinal cord,
which caused the dose results calculated using the AAA
to be higher than those calculated using the CCCS algo-
rithm. Fogliata et al. have reported similar results [40].
These results indicate that compared with the uniform-
phantom-based dosimetric verification method, the
complete 3D dosimetric verification method using an in-
dependent dose-calculation algorithm can provide more
detailed evaluation information.
The advantage of the GPU implementation of the
CCCS algorithm is that the 3D dose computation time is
significantly reduced, while the necessary accuracy of thema evaluations
(s) CCCS(s) Gamma evaluation (s)
TERMA CS Resampling Gamma calculation
0.030 6.822 0.762 0.821
0.028 5.965 0.522 0.709
0.054 7.324 0.804 0.847
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These advantages are important for 3D dosimetric tech-
niques that are intended to be applied in labor-intensive
clinical verifications. For either pre-treatment or in vivo
dosimetric verifications, GPU-based dose reconstruction
can achieve true real-time calculations. Chen et al. have
reported that the single-field computation time can
reach 0.5 s when two higher-performance GPUs and a
fully optimized CCCS algorithm are used [19]. In this
study, for the three different sites considered (which
contained 160 × 100 × 72, 180 × 50 × 76 and 136 × 120 ×
106 voxels), the single-field dose-reconstruction times
were 7 s, 6 s and 8 s, respectively. Thus, our study indi-
cates that there is room for further improvement: 1)
High-performance hardware can effectively improve the
computation speed. An NVIDIA GTX-765 M notebook
video card with 768 CUDA cores was used to perform
the computations reported in this study. When we per-
formed the computations on an NVIDIA GTX-TITAN,
which contains 2688 CUDA cores, the computation
speed was 5-6 times faster than that achieved using the
GTX-765 M. 2) Optimization of the CCCS algorithm
can also improve the computation speed. Here, we used
the lookup method based on tabulated kernels for the
calculation. The computation time could be reduced by
using the exponential kernel model and the built-in
NVIDIA special function unit.
Not only the dose calculation but also the fluence-map
reconstruction and the gamma-index calculation were
implemented using the GPU. The computation time re-
quired to obtain a fluence map from EPID images of
1024 × 768 pixels was reduced to 0.3 s by computing
FFTs in parallel on the NVIDIA GPU. By contrast, the
computation time that was required when a single CPU
was used was approximately 8 s. Wendling et al. have
presented a fast algorithm for gamma calculation, for
which the computation time for a 38.5 cm × 35.3 cm ×
25.3 cm dose dataset at a 0.1-cm grid resolution was
found to be 28 s [34]. This algorithm still represents a
non-negligible time cost for real-time clinical verifica-
tions. With the gamma calculation implemented using a
GPU, the computation time, including data resampling
and gamma calculation, for a 48.0 cm × 30.0 cm ×
21.6 cm dose dataset at a 0.1-cm grid resolution was
found to be less than 1.8 s.
Conclusion
A 3D pre-treatment dosimetric verification method
based on an EPID was presented. A GPU calculation en-
gine can boost the speed of 3D dose and gamma evalu-
ation calculations, thereby bringing the calculation and
evaluation times to the level required for real-time verifi-
cations. Although this investigation focused on pre-
treatment dosimetric verification, it is our intent toextend the methodology to true real-time 3D dosimetric
verification using EPID transit measurements and a
GPU calculation engine.
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